9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Companies
/Healthcare
Pfizer Inc
$27.74
▲ $0.08 (+0.29%) today
Markets closed · 2:58am ET
PFE Coverage
Page 326:35am ET
Investing
The 6 Most Shorted Dow Stocks
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
6:50am ET
Investing
The 5 Most Shorted Dow Stocks
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
6:35am ET
Investing
The 6 Most Shorted Dow Stocks
As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.
12:10pm ET
Health and Healthcare
Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
8:40am ET
Health and Healthcare
Major Pharma Sees Rising Tide in Short Interest
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
6:35am ET
Investing
Pfizer Once Again the Most Shorted Dow Stock
As of the most recently reported period, short sellers still favored Pfizer, Intel and Microsoft above all other Dow stocks.
1:05pm ET
Investing
Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019
Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas, 10 tied mostly to retailing of apparel and accessories, and six are…
10:45am ET
Health and Healthcare
Is GlycoMimetics’ Sickle Cell Study Done For?
GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction with Pfizer.
Chris Lange 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included Cisco Systems, Duke Energy, Goodyear, Illumina, Kinder Morgan, Micron Technology, Pfizer and Tencent Music.
12:05pm ET
Health and Healthcare
What to Watch When Merck and Pfizer Report Early on Tuesday
Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of the Dow Jones industrials that are reporting this week, but they make…
9:25am ET
Health and Healthcare
What This Mylan-Pfizer Pharma Juggernaut Will Look Like
Mylan released its second-quarter financial results before the markets opened on Monday. The pharma giant also announced a major update to its business involving Pfizer and that CEO Heather Bresch is resigning.
10:20am ET
Investing
Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including Apple, Exxon and Pfizer.